Physician

John Scott Renshaw, M.D.

According to 2025 Medicare claims, John Renshaw, M.D. (NPI: 1518168442) practices hematology/oncology in the San Antonio-New Braunfels, TX market, with the plurality of this provider's patient population coming from Bexar, TX. This provider's primary affiliated billing organization is TEXAS ONCOLOGY PA (NPI: 1811944101; TIN: 752131429) and primary practice location at 78240-5251. Renshaw is affiliated with the CoreHealth Alliance LLC (ACO ID: A5645) and Prime Accountable Care East LLC (ACO ID: D0343), participating under both the MSSP and REACH models.

Renshaw's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 688 traditional Medicare patients, billed 139,951 HCPCS/CPT codes, and received $2,002,922 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,484 prescription claims across 234 beneficiaries totaling $5,031,895 in drug costs, led by Jakafi (Ruxolitinib Phosphate). Open Payments data shows 106 records totaling $414,956. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $90,955 to $2,002,922. Similarly, Part D prescription costs have moved sharply higher in recent years, from $136,539 to $5,031,895. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.